“In 2013? Um gene therapy was starting to work a man as you well know 2008 was a huge disruption to the world into the capital markets and a lot of capital was sitting on the sidelines for a few years and then right around 2012 or 2013 the capital market started recovering people were looking for things to invest in and biotech became a ah big one and there were 3 real major areas where where investors started coming into biotech was in cancer immunotherapy.”